End-of-day quote
Taiwan S.E.
18:00:00 2024-05-16 EDT
|
5-day change
|
1st Jan Change
|
166.5
TWD
|
-2.35%
|
|
-2.35%
|
+23.79%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
12,525
|
14,115
|
19,530
|
35,100
|
28,625
|
33,625
|
Enterprise Value (EV)
1 |
12,105
|
14,851
|
20,174
|
36,955
|
31,349
|
37,055
|
P/E ratio
|
13.6
x
|
16.1
x
|
16.7
x
|
21.8
x
|
15.8
x
|
21.4
x
|
Yield
|
5.99%
|
2.34%
|
3.22%
|
1.71%
|
3.14%
|
2.38%
|
Capitalization / Revenue
|
1.56
x
|
1.88
x
|
2.51
x
|
3.15
x
|
2.52
x
|
3.41
x
|
EV / Revenue
|
1.51
x
|
1.98
x
|
2.59
x
|
3.32
x
|
2.76
x
|
3.76
x
|
EV / EBITDA
|
9.67
x
|
12
x
|
12.2
x
|
16.7
x
|
12.7
x
|
15.9
x
|
EV / FCF
|
-94.3
x
|
-23.7
x
|
84
x
|
-41.9
x
|
-50.6
x
|
-256
x
|
FCF Yield
|
-1.06%
|
-4.22%
|
1.19%
|
-2.39%
|
-1.97%
|
-0.39%
|
Price to Book
|
2.6
x
|
2.87
x
|
3.39
x
|
5.17
x
|
3.56
x
|
3.86
x
|
Nbr of stocks (in thousands)
|
250,000
|
250,000
|
250,000
|
250,000
|
250,000
|
250,000
|
Reference price
2 |
50.10
|
56.46
|
78.12
|
140.4
|
114.5
|
134.5
|
Announcement Date
|
19-02-27
|
20-02-26
|
21-02-26
|
22-02-25
|
23-02-28
|
24-02-29
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
8,034
|
7,508
|
7,778
|
11,144
|
11,345
|
9,853
|
EBITDA
1 |
1,252
|
1,234
|
1,659
|
2,214
|
2,477
|
2,334
|
EBIT
1 |
1,051
|
989.2
|
1,375
|
1,908
|
2,096
|
1,841
|
Operating Margin
|
13.09%
|
13.18%
|
17.68%
|
17.12%
|
18.48%
|
18.68%
|
Earnings before Tax (EBT)
1 |
1,156
|
1,086
|
1,452
|
2,003
|
2,247
|
1,925
|
Net income
1 |
930.1
|
884.9
|
1,174
|
1,617
|
1,825
|
1,578
|
Net margin
|
11.58%
|
11.79%
|
15.09%
|
14.51%
|
16.09%
|
16.02%
|
EPS
2 |
3.684
|
3.510
|
4.666
|
6.432
|
7.250
|
6.280
|
Free Cash Flow
1 |
-128.4
|
-626.5
|
240.2
|
-882.2
|
-619
|
-145
|
FCF margin
|
-1.6%
|
-8.34%
|
3.09%
|
-7.92%
|
-5.46%
|
-1.47%
|
FCF Conversion (EBITDA)
|
-
|
-
|
14.48%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
20.46%
|
-
|
-
|
-
|
Dividend per Share
2 |
3.000
|
1.320
|
2.512
|
2.400
|
3.600
|
3.200
|
Announcement Date
|
19-02-27
|
20-02-26
|
21-02-26
|
22-02-25
|
23-02-28
|
24-02-29
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
736
|
644
|
1,855
|
2,724
|
3,430
|
Net Cash position
1 |
420
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.5968
x
|
0.3883
x
|
0.838
x
|
1.1
x
|
1.469
x
|
Free Cash Flow
1 |
-128
|
-627
|
240
|
-882
|
-619
|
-145
|
ROE (net income / shareholders' equity)
|
20%
|
18.2%
|
22%
|
25.8%
|
24.6%
|
18.9%
|
ROA (Net income/ Total Assets)
|
11.1%
|
9.45%
|
11.3%
|
12.4%
|
10.7%
|
8.21%
|
Assets
1 |
8,352
|
9,362
|
10,400
|
12,999
|
17,040
|
19,219
|
Book Value Per Share
2 |
19.20
|
19.70
|
23.10
|
27.10
|
32.20
|
34.80
|
Cash Flow per Share
2 |
1.680
|
0.5100
|
1.780
|
1.210
|
1.860
|
1.110
|
Capex
1 |
636
|
1,470
|
844
|
1,941
|
2,544
|
1,907
|
Capex / Sales
|
7.92%
|
19.57%
|
10.85%
|
17.42%
|
22.42%
|
19.36%
|
Announcement Date
|
19-02-27
|
20-02-26
|
21-02-26
|
22-02-25
|
23-02-28
|
24-02-29
|
|
1st Jan change
|
Capi.
|
---|
| +23.79% | 1.33B | | +5.41% | 105B | | -3.11% | 64.71B | | +73.33% | 49.72B | | +17.24% | 38.6B | | +6.13% | 32.54B | | +12.77% | 19.94B | | +15.03% | 16.92B | | +19.06% | 15.2B | | +6.28% | 14.39B |
Other Commodity Chemicals
|